Federal Register / Vol. 90, No. 5 / Wednesday, January 8, 2025 / Notices 1495 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Public Health Ethics and 

Regulations, Office of Science, Centers for 

Disease Control and Prevention. 

[FR Doc. 2025–00164 Filed 1–7–25; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60–Day–25–0666; Docket No. CDC–2025– 

0001] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing effort to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other federal 

agencies the opportunity to comment on 

a proposed and/or continuing 

information collection, as required by 

the Paperwork Reduction Act of 1995. 

This notice invites comment on a 

proposed information collection project 

titled Pathogens of High Consequence, 

which assesses the incidence and 

prevalence of select high consequence 

pathogens of public health importance 

in acute care hospitals. In addition to 

the nine diseases approved for 

collection, the following three 

additional diseases are being added to 

the form: Influenza A (H5), Marburg, 

and Oropouche. 

DATES: CDC must receive written 

comments on or before March 10, 2025. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2025– 

0001 by either of the following methods: 

• Federal eRulemaking Portal: 

www.regulations.gov. Follow the 

instructions for submitting comments. 

• Mail: Jeffrey M. Zirger, Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, MS H21–8, Atlanta, 

Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. CDC will post, without 

change, all relevant comments to 

www.regulations.gov. 

Please note: Submit all comments 

through the Federal eRulemaking portal 

(www.regulations.gov) or by U.S. mail to 

the address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 

instruments, contact Jeffrey M. Zirger, 

Information Collection Review Office, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road, NE, MS 

H21–8, Atlanta, Georgia 30329; 

Telephone: 404–639–7570; Email: omb@

cdc.gov. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. In addition, the PRA also 

requires federal agencies to provide a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each new 

proposed collection, each proposed 

extension of existing collection of 

information, and each reinstatement of 

previously approved information 

collection before submitting the 

collection to the OMB for approval. To 

comply with this requirement, we are 

publishing this notice of a proposed 

data collection as described below. 

The OMB is particularly interested in 

comments that will help: 

1. Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

2. Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

3. Enhance the quality, utility, and 

clarity of the information to be 

collected; 

4. Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submissions 

of responses; and 

5. Assess information collection costs. 

Proposed Project 

National Healthcare Safety Network 

(NHSN) (OMB Control No. 0920–0666, 

Exp. 12/31/2027)—Revision— 

Information Collection Request— 

National Center for Emerging and 

Zoonotic Infection Diseases (NCEZID), 

Centers for Disease Control and 

Prevention (CDC). 

Background and Brief Description 

The Division of Healthcare Quality 

Promotion (DHQP), National Center for 

Emerging and Zoonotic Infectious 

Diseases (NCEZID), Centers for Disease 

Control and Prevention (CDC) collects 

data from healthcare facilities in the 

National Healthcare Safety Network 

(NHSN) under OMB Control Number 

0920–0666. NHSN provides facilities, 

health departments, states, regions, and 

the nation with data necessary to 

identify problem areas, measure the 

progress of prevention efforts, and 

ultimately eliminate healthcareassociated infections (HAIs) nationwide. 

NHSN also allows healthcare facilities 

to track blood safety errors and various 

HAI prevention practice methods such 

as healthcare personnel influenza 

vaccine status and corresponding 

infection control adherence rates. 

Enrollment in NHSN has 

continuously increased, with over 

37,000 actively reporting healthcare 

facilities across the U.S. Of the total 

enrolled healthcare facilities, there are 

over 6,000 acute care facilities. NHSN 

currently has eight components, and the 

collection of information is authorized 

by the Public Health Service Act (42 

U.S.C. 242b, 242k, and 242m (d)), 

(Attachment A1–A3). Data reported 

under NHSN’s Patient Safety 

Component are used to determine the 

magnitude of the healthcare-associated 

adverse events and trends in the rates of 

the events, in the distribution of 

pathogens, and in the adherence to 

prevention practices. Data will help 

detect changes in the epidemiology of 

adverse events resulting from new 

medical therapies and changing patient 

risks. Additionally, reported data is 

being used to describe the epidemiology 

of antimicrobial use and resistance and 

to better understand the relationship of 

antimicrobial therapy to this rising 

problem. 

NHSN’s data is used to aid in the 

tracking of HAIs and guide infection 

prevention activities/practices that 

protect patients. The Centers for 

Medicare and Medicaid Services (CMS) 

and other payers use these data to 

determine incentives for performance at 

healthcare facilities across the U.S. and 

surrounding territories, and members of 

the public may use some protected data 

to inform their selection among 

available providers.Each of these parties 

is dependent on the completeness and 

accuracy of the data. CDC and CMS 

work closely and are fully committed to 

ensuring complete and accurate 

reporting, which are critical for 

protecting patients and guiding 


lotter on DSK11XQN23PROD with NOTICES1
1496 Federal Register / Vol. 90, No. 5 / Wednesday, January 8, 2025 / Notices 

national, state, and local prevention 

priorities. 

This Revision includes an update to 

add three diseases included as part of 

Form 57.130—Pathogens of High 

Consequence. The original collection 

captured the number of patients newly 

admitted and currently hospitalized 

with certain diseases in acute care 

hospitals (e.g.,. Crimean-Congo 

Hemorrhagic Fever (CCHF), Dengue, 

Ebola, Lassa, Measles, Mpox, MERSCoV, Nipah, and Toxigenic Vibrio 

cholerae) broken down by adult patients 

and pediatric patients. Three additional 

diseases are being added to the data 

collection, Influenza A (H5), Marburg, 

and Oropouche. Influenza A (H5) has 

been on the CDC’s Office of Readiness 

and Response website as an active 

response. Marburg and Oropouche were 

recently added to the website as active 

responses due to international 

outbreaks. It is crucial for CDC to be 

aware of cases of these select infectious 

diseases of public health concern to 

help ensure that local and state 

authorities are equipped to contain and 

prevent further spread. Facilities 

enrolled in the NHSN Patient Safety 

Component will be asked to select the 

specific diseases they are reporting on 

and then provide the overall number of 

patients hospitalized with confirmed 

disease along with stratification of 

disease in adult and pediatric patients. 

The data collection will be collected 

electronically via the NHSN application. 

This Revision requests OMB approval 

for an estimated 111,021 annual burden 

hours to be added to Form 57.130— 

Pathogens of High Consequence. The 

total estimated annual burden hours for 

the NHSN package will be increased to 

4,508,255. Participation is required for 

healthcare facilities that report through 

the NHSN platform. There is no cost to 

respondents other than their time to 

participate. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total burden 

(in hours) 

Infection Preventionist/Microbiologist 57.130 Pathogens of High Consequence.3,650 365 5/60 111,021 

Total ........................................... ........................................................... ........................ ........................ ........................ 4,508,255 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Public Health Ethics and 

Regulations, Office of Science, Centers for 

Disease Control and Prevention. 

[FR Doc. 2025–00165 Filed 1–7–25; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–25–0469; Docket No. CDC–2024– 

0105] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing effort to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other federal 

agencies the opportunity to comment on 

a continuing information collection, as 

required by the Paperwork Reduction 

Act of 1995. This notice invites 

comment on a proposed information 

collection project titled National 

Program of Cancer Registries Cancer 

Surveillance System. This information 

collection creates a Cancer Registry that 

provides useful data on cancer 

incidence, trends, and outcomes. 

DATES: CDC must receive written 

comments on or before March 10, 2025. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2024– 

0105 by either of the following methods: 

• Federal eRulemaking Portal: 

www.regulations.gov. Follow the 

instructions for submitting comments. 

• Mail: Jeffrey M. Zirger, Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road, NE, MS–D74, Atlanta, 

Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. CDC will post, without 

change, all relevant comments to 

www.regulations.gov. 

Please note: Submit all comments 

through the Federal eRulemaking portal 

(www.regulations.gov) or by U.S. mail to 

the address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 

instruments, contact Jeffrey M. Zirger, 

Information Collection Review Office, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road, NE, MS– 

D74, Atlanta, Georgia 30329; Telephone: 

404–639–7570; Email: omb@cdc.gov. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. In addition, the PRA also 

requires federal agencies to provide a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each new 

proposed collection, each proposed 

extension of existing collection of 

information, and each reinstatement of 

previously approved information 

collection before submitting the 

collection to the OMB for approval. To 

comply with this requirement, we are 

publishing this notice of a proposed 

data collection as described below. 

The OMB is particularly interested in 

comments that will help: 

1. Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

2. Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

3. Enhance the quality, utility, and 

clarity of the information to be 

collected; 

4. Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 


lotter on DSK11XQN23PROD with NOTICES1